|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
JP2532858B2
(ja)
|
1985-04-01 |
1996-09-11 |
セルテツク リミテツド |
形質転換したミエロ―マ細胞系
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
WO1987005330A1
(en)
|
1986-03-07 |
1987-09-11 |
Michel Louis Eugene Bergh |
Method for enhancing glycoprotein stability
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
EP0318554B2
(en)
|
1987-05-21 |
2005-01-12 |
Micromet AG |
Targeted multifunctional proteins
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
KR900700134A
(ko)
|
1988-04-15 |
1990-08-11 |
원본미기재 |
Il-2 수용체-특이적 키메릭 항체
|
|
ATE120454T1
(de)
|
1988-06-14 |
1995-04-15 |
Cetus Oncology Corp |
Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus.
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
ZA902949B
(en)
|
1989-05-05 |
1992-02-26 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
CA2078689C
(en)
|
1990-03-20 |
2003-02-11 |
Sherie L. Morrison |
Chimeric antibodies with receptor binding ligands in place of their constant region
|
|
DE69133036T2
(de)
|
1990-11-09 |
2003-02-06 |
Stephen D. Gillies |
Cytokine immunokonjugate
|
|
IE922437A1
(en)
|
1991-07-25 |
1993-01-27 |
Idec Pharma Corp |
Recombinant antibodies for human therapy
|
|
NZ255101A
(en)
|
1992-07-24 |
1997-08-22 |
Cell Genesys Inc |
A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
|
|
WO1994009817A1
(en)
|
1992-11-04 |
1994-05-11 |
City Of Hope |
Novel antibody construct
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
EP0669986B1
(en)
|
1992-11-13 |
2003-04-09 |
Idec Pharmaceuticals Corporation |
Fully impaired consensus kozac sequences for mammalian expression
|
|
CA2116280A1
(en)
|
1993-03-05 |
1994-09-06 |
Marcy E. Macdonald |
Huntingtin dna, protein and uses thereof
|
|
ATE390933T1
(de)
|
1995-04-27 |
2008-04-15 |
Amgen Fremont Inc |
Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
US6255455B1
(en)
*
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
|
RO120148B1
(ro)
|
1997-03-14 |
2005-09-30 |
Idec Pharmaceuticals Corporation |
Sistem vector şi procedeu de inserţie a unui fragment adn, în genomul celulelor de mamifere
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
WO1999006838A2
(en)
|
1997-08-01 |
1999-02-11 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel method of detecting amyloid-like fibrils or protein aggregates
|
|
AU1631700A
(en)
|
1998-11-23 |
2000-06-13 |
Idec Pharmaceuticals Corporation |
Tumor antigen-specific antibody-gp39 chimeric protein constructs
|
|
ATE352559T1
(de)
|
1998-12-08 |
2007-02-15 |
Biovation Ltd |
Verfahren zur verminderung der immunogenität von proteinen
|
|
WO2001006989A2
(en)
*
|
1999-07-27 |
2001-02-01 |
Abgenix, Inc. |
Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
|
|
DE60126130T2
(de)
|
2000-11-17 |
2007-10-18 |
The University Of Rochester |
In-vitro verfahren zur herstellung und identifizierung von immunglobulin moleküle in eukaryotischen zellen
|
|
WO2002096948A2
(en)
|
2001-01-29 |
2002-12-05 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
|
IL157142A0
(en)
|
2001-01-29 |
2004-02-08 |
Idec Pharma Corp |
Modified antibodies and methods of use
|
|
ATE382704T1
(de)
*
|
2001-02-15 |
2008-01-15 |
Univ Chicago |
Verfahren zum nachweis in hefe für mittels die proteinfaltung beeinflussen
|
|
US20030157641A1
(en)
|
2001-11-16 |
2003-08-21 |
Idec Pharmaceuticals Corporation |
Polycistronic expression of antibodies
|
|
US7375194B2
(en)
|
2002-01-28 |
2008-05-20 |
California Institute Of Technology |
Antibodies that bind to an epitope on the Huntington's disease protein
|
|
US7589189B2
(en)
*
|
2003-05-14 |
2009-09-15 |
Japan Science And Technology Agency |
Inhibition of the expression of huntingtin gene
|
|
CN1871259A
(zh)
|
2003-08-22 |
2006-11-29 |
比奥根艾迪克Ma公司 |
具有改变的效应物功能的经改进的抗体和制备它的方法
|
|
US20050226863A1
(en)
|
2003-11-20 |
2005-10-13 |
Massachusetts Institute Of Technology |
Single-domain antibodies and uses thereof
|
|
SI2436696T1
(sl)
*
|
2007-01-05 |
2017-10-30 |
University Of Zurich |
Anti-beta-amiloidno protitelo in načini njegove uporabe
|
|
US20090304590A1
(en)
*
|
2007-05-29 |
2009-12-10 |
Wyeth |
Therapeutic compositions and methods
|
|
US8022268B2
(en)
*
|
2007-06-11 |
2011-09-20 |
The University Of Zurich |
Transgenic animal model for alzheimer's disease
|
|
EA030826B1
(ru)
|
2008-12-19 |
2018-10-31 |
Панима Фармасьютикалз Аг |
ЧЕЛОВЕЧЕСКИЕ АУТОАНТИТЕЛА ПРОТИВ α-СИНУКЛЕИНА
|
|
PT2627672T
(pt)
|
2010-10-11 |
2018-11-16 |
Univ Zuerich |
Anticorpos anti-tau humanos
|
|
JP6067575B2
(ja)
|
2010-12-17 |
2017-01-25 |
ニューリミューン ホールディング エイジー |
ヒト抗ｓｏｄ１抗体
|
|
WO2012113775A1
(en)
|
2011-02-21 |
2012-08-30 |
University Of Zurich |
Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
|
|
CA2842169A1
(en)
*
|
2011-07-20 |
2013-01-24 |
Medimmune Limited |
Anti-cxcr4 antibodies and methods of use
|
|
WO2013061163A2
(en)
|
2011-10-28 |
2013-05-02 |
Biogen Idec International Neuroscience Gmbh |
Tdp-43 specific binding molecules
|
|
DK3071598T3
(da)
*
|
2013-05-29 |
2021-09-13 |
Vybion Inc |
Enkeltkædede intrabodies, der ændrer nedbrydning af huntingtin-mutant
|
|
DK3166660T3
(en)
*
|
2014-07-10 |
2018-02-05 |
Affiris Ag |
SUBSTANCES AND PROCEDURES FOR USE IN PREVENTION AND / OR TREATMENT OF HUNTINGTON'S DISEASE
|
|
AU2015286604B2
(en)
*
|
2014-07-10 |
2019-08-15 |
Hd Immune Gmbh |
Substances and methods for the use in prevention and/or treatment in Huntington's disease
|
|
CN107074937B
(zh)
*
|
2014-07-29 |
2021-07-27 |
神经免疫控股公司 |
人源抗亨廷顿蛋白(htt)抗体及其用途
|